Many abstracts about myeloma being presented at ASH 2025 were also presented at the International Myeloma Society (IMS) ...
Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with ...
Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with ...
Game Rant on MSN
Open-World Games That Change With Every Journey
If you want to find your forever game, these open-world experiences can offer new ways to play each time you boot them up.
Discusses Progress and Future Plans for Skin Scarring Program November 25, 2025 7:00 PM ESTCompany ParticipantsGary Phillips ...
The internet you know—the one you're surfing to read this article—is just the tip of the iceberg. Beneath the surface lies the dark web: a hidden layer of the internet that's invisible to most users, ...
A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and ...
Praxis Precision Medicines, Inc. ( PRAX) Discusses Essential3 Program and Statistical Modeling Approaches in Clinical Studies November 24, 2025 1:00 PM EST Douglas Tsao - H.C. Wainwright & Co, LLC, ...
Trial met primary endpoint of hemoglobin response and key secondary endpoints of change from baseline in hemoglobin concentration and indirect ...
Operator: Good day, and thank you for standing by. Welcome to the Valneva 9 Months 2025 Financial Results Conference Call and Webcast.
Trial met primary endpoint of hemoglobin response and key secondary endpoints of change from baseline in hemoglobin concentration and indirect bilirubin Trial showed trend favoring mitapivat but did ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback